Connection

Malik Peiris to Adult

This is a "connection" page, showing publications Malik Peiris has written about Adult.
Connection Strength

0.139
  1. Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
    View in: PubMed
    Score: 0.015
  2. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease. Emerg Infect Dis. 2020 11; 26(11):2701-2704.
    View in: PubMed
    Score: 0.015
  3. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020 04; 25(16).
    View in: PubMed
    Score: 0.014
  4. Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis. 2018 08 24; 218(7):1054-1060.
    View in: PubMed
    Score: 0.013
  5. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill. 2015; 20(49).
    View in: PubMed
    Score: 0.010
  6. Is exercise protective against influenza-associated mortality? PLoS One. 2008 May 07; 3(5):e2108.
    View in: PubMed
    Score: 0.006
  7. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003 May 24; 361(9371):1773-8.
    View in: PubMed
    Score: 0.004
  8. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat Commun. 2021 07 29; 12(1):4678.
    View in: PubMed
    Score: 0.004
  9. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 03; 21(3):385-395.
    View in: PubMed
    Score: 0.004
  10. In-Flight Transmission of SARS-CoV-2. Emerg Infect Dis. 2020 11; 26(11):2713-2716.
    View in: PubMed
    Score: 0.004
  11. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1293-1301.
    View in: PubMed
    Score: 0.004
  12. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020 07; 8(7):687-695.
    View in: PubMed
    Score: 0.004
  13. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 06; 20(6):656-657.
    View in: PubMed
    Score: 0.004
  14. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 03 19; 382(12):1177-1179.
    View in: PubMed
    Score: 0.004
  15. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Euro Surveill. 2019 Nov; 24(48).
    View in: PubMed
    Score: 0.004
  16. Transmissibility of MERS-CoV Infection in Closed Setting, Riyadh, Saudi Arabia, 2015. Emerg Infect Dis. 2019 10; 25(10):1802-1809.
    View in: PubMed
    Score: 0.003
  17. Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019 04 10; 10(1):1660.
    View in: PubMed
    Score: 0.003
  18. Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community. Clin Infect Dis. 2017 03 15; 64(6):736-742.
    View in: PubMed
    Score: 0.003
  19. A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes. PLoS One. 2016; 11(11):e0165978.
    View in: PubMed
    Score: 0.003
  20. Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection. Epidemiology. 2015 Sep; 26(5):666-9.
    View in: PubMed
    Score: 0.003
  21. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015; 20(41).
    View in: PubMed
    Score: 0.003
  22. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses. 2015 Mar; 9(2):64-7.
    View in: PubMed
    Score: 0.002
  23. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014 Jun; 20(6):1049-53.
    View in: PubMed
    Score: 0.002
  24. Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. BMC Immunol. 2009 Jun 08; 10:35.
    View in: PubMed
    Score: 0.002
  25. Association of ICAM3 genetic variant with severe acute respiratory syndrome. J Infect Dis. 2007 Jul 15; 196(2):271-80.
    View in: PubMed
    Score: 0.001
  26. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis. 2007 Jun 01; 7:50.
    View in: PubMed
    Score: 0.001
  27. The large 386-nt deletion in SARS-associated coronavirus: evidence for quasispecies? J Infect Dis. 2006 Sep 15; 194(6):808-13.
    View in: PubMed
    Score: 0.001
  28. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005 May 15; 191(10):1697-704.
    View in: PubMed
    Score: 0.001
  29. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.